Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Iterum Therapeutics has raised $2.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2025.
Iterum Therapeutics's investors include RA Capital Management, Canaan Partners, Sofinnova Investments, Frazier Healthcare Partners, Pivotal bioVenture Partners.
Iterum Therapeutics is headquartered in Dublin, Ireland.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Iterum Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iterum Therapeutics — Funding & Investors." VCBacked, August 1, 2025, https://www.vcbacked.co/company/iterum-therapeutics. Accessed August 15, 2026.
VCBacked. (2025). Iterum Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/iterum-therapeutics
{{cite web |title=Iterum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iterum-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated